Behrens, D.; Pfohl, U.; Conrad, T.; Becker, M.; Brzezicha, B.; Büttner, B.; Wagner, S.; Hallas, C.; Lawlor, R.; Khazak, V.;
et al. Establishment and Thorough Characterization of Xenograft (PDX) Models Derived from Patients with Pancreatic Cancer for Molecular Analyses and Chemosensitivity Testing. Cancers 2023, 15, 5753.
https://doi.org/10.3390/cancers15245753
AMA Style
Behrens D, Pfohl U, Conrad T, Becker M, Brzezicha B, Büttner B, Wagner S, Hallas C, Lawlor R, Khazak V,
et al. Establishment and Thorough Characterization of Xenograft (PDX) Models Derived from Patients with Pancreatic Cancer for Molecular Analyses and Chemosensitivity Testing. Cancers. 2023; 15(24):5753.
https://doi.org/10.3390/cancers15245753
Chicago/Turabian Style
Behrens, Diana, Ulrike Pfohl, Theresia Conrad, Michael Becker, Bernadette Brzezicha, Britta Büttner, Silvia Wagner, Cora Hallas, Rita Lawlor, Vladimir Khazak,
and et al. 2023. "Establishment and Thorough Characterization of Xenograft (PDX) Models Derived from Patients with Pancreatic Cancer for Molecular Analyses and Chemosensitivity Testing" Cancers 15, no. 24: 5753.
https://doi.org/10.3390/cancers15245753
APA Style
Behrens, D., Pfohl, U., Conrad, T., Becker, M., Brzezicha, B., Büttner, B., Wagner, S., Hallas, C., Lawlor, R., Khazak, V., Linnebacher, M., Wartmann, T., Fichtner, I., Hoffmann, J., Dahlmann, M., & Walther, W.
(2023). Establishment and Thorough Characterization of Xenograft (PDX) Models Derived from Patients with Pancreatic Cancer for Molecular Analyses and Chemosensitivity Testing. Cancers, 15(24), 5753.
https://doi.org/10.3390/cancers15245753
